Murtaza et al. found that fisetin inhibited the growth of pancreatic cancer AsPC-1 cells through death receptor 3 (DR3)-mediated inhibition of the nuclear factor kappa B (NF-κB) pathway11. This evidence concerns the gene TNFRSF25 and familial pancreatic carcinoma.